Skip to main content
Signal8

Gilead Sciences and World Health Organization Expand Collaboration to Help Eliminate Visceral Leishmaniasis, a Fatal Parasitic Disease

$GILDPress releaseMay 21, 2026, 3:30 AM ETRead the release

Gilead Sciences renewed its five-year collaboration with the World Health Organization to help eliminate visceral leishmaniasis, a fatal parasitic disease. The agreement includes a commitment of $9.2 million in financial support and more than 400,000 vials of AmBisome through 2030, focusing on high-burden countries in East Africa.

Key figures

Financial support
$9.2 million
Product donation vials
400,000
Partnership duration years
5

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    GILD: Gilead Sciences and World Health Organization Expand Collaboration to Help Eliminate Visceral Leishmaniasis, a Fatal Parasitic Disease — AI Analysis | Signal8